Ignite Creation Date:
2024-07-17 @ 11:19 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06462742
Status:
RECRUITING
Last Update Posted:
2024-06-18
First Post:
2024-06-12
Brief Title:
Microwave Ablation Versus Liver Resection for Intrahepatic Cholangiocarcinoma
Sponsor:
Chinese PLA General Hospital
Organization:
Chinese PLA General Hospital
Study Overview
Official Title:
Microwave Ablation Versus Liver Resection for Intrahepatic Cholangiocarcinoma Within Milan Criteria
Status:
RECRUITING
Status Verified Date:
2024-07
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
MALRIC
Brief Summary:
Thermal ablation has been recommended by worldwide guidelines as first-line treatment for hepatocellular carcinoma HCC while evidence regarding its efficacy for primary intrahepatic cholangiocarcinoma iCCA is lacking The goal of this observational study is to study the efficacy of ablation in treating iCCA by comparing its prognosis with surgery The main questions it aims to answer are
Whether microwave ablation could achieve similar efficacy with liver resection in treating iCCA
What is the risk factor for ablation or surgery in treating iCCA
What kind of iCCA patients could receive ablation as their first-line treatment In this real-world multicenter cohort study we will collect data of iCCA patients from hospitals who underwent microwave ablation MWA or liver resection LR for tumors within Milan criteria Survival will be compared between patients treated by MWA or LR
Whether microwave ablation could achieve similar efficacy with liver resection in treating iCCA
What is the risk factor for ablation or surgery in treating iCCA
What kind of iCCA patients could receive ablation as their first-line treatment In this real-world multicenter cohort study we will collect data of iCCA patients from hospitals who underwent microwave ablation MWA or liver resection LR for tumors within Milan criteria Survival will be compared between patients treated by MWA or LR
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None